Nitric oxide, phosphodiesterase inhibition, and adaptation to hypoxic conditions

Lancet. 2002 May 4;359(9317):1539-40. doi: 10.1016/s0140-6736(02)08528-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors*
  • Adaptation, Physiological*
  • Altitude Sickness / etiology
  • Altitude Sickness / metabolism*
  • Altitude Sickness / prevention & control*
  • Animals
  • Bolivia
  • Humans
  • Hypertension, Pulmonary / ethnology
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / metabolism*
  • Hypertension, Pulmonary / prevention & control*
  • Hypoxia / complications
  • Hypoxia / metabolism*
  • Nitric Oxide / metabolism*
  • Oxygen / metabolism
  • Phosphodiesterase Inhibitors / pharmacology*
  • Rats
  • Tibet

Substances

  • Phosphodiesterase Inhibitors
  • Nitric Oxide
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Oxygen